Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies

ABSTRACT In medical product development, there has been an increased interest in utilizing real-world data which have become abundant with recent advances in biomedical science, information technology, and engineering. High-quality real-world data may be analyzed to generate real-world evidence that can be utilized in the regulatory and healthcare decision-making. In this paper, we consider the case in which a single-arm clinical study, viewed as the primary data source, is supplemented with patients from a real-world data source containing both clinical outcome and covariate data at the patient-level. Propensity score methodology is used to identify real-world data patients that are similar to those in the single-arm study in terms of the baseline characteristics, and to stratify these patients into strata based on the proximity of the propensity scores. In each stratum, a composite likelihood function of a parameter of interest is constructed by down-weighting the information from the real-world data source, and an estimate of the stratum-specific parameter is obtained by maximizing the composite likelihood function. These stratum-specific estimates are then combined to obtain an overall population-level estimate of the parameter of interest. The performance of the proposed approach is evaluated via a simulation study. A hypothetical example based on our experience is provided to illustrate the implementation of the proposed approach.

[1]  D. Rubin For objective causal inference, design trumps analysis , 2008, 0811.1640.

[2]  N. Reid,et al.  AN OVERVIEW OF COMPOSITE LIKELIHOOD METHODS , 2011 .

[3]  Jeremy A Rassen,et al.  Metrics for covariate balance in cohort studies of causal effects , 2014, Statistics in medicine.

[4]  Harry Joe,et al.  Composite Likelihood Methods , 2012 .

[5]  Jerome P. Reiter,et al.  A comparison of two methods of estimating propensity scores after multiple imputation , 2016, Statistical methods in medical research.

[6]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[7]  Michael Gabay,et al.  21st Century Cures Act , 2017 .

[8]  V. P. Godambe An Optimum Property of Regular Maximum Likelihood Estimation , 1960 .

[9]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[10]  Gregory Campbell,et al.  Utilizing national and international registries to enhance pre-market medical device regulatory evaluation , 2016, Journal of biopharmaceutical statistics.

[11]  J. Lunceford,et al.  Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study , 2004, Statistics in medicine.

[12]  Heng Li,et al.  A Note on Good Practice of Objective Propensity Score Design for Premarket Nonrandomized Medical Device Studies with an Example , 2016 .

[13]  D. Rubin The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials , 2007, Statistics in medicine.

[14]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[15]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[16]  Elizabeth A Stuart,et al.  Improving propensity score weighting using machine learning , 2010, Statistics in medicine.

[17]  Yunling Xu,et al.  Designing Premarket Observational Comparative Studies Using Existing Data as Controls: Challenges and Opportunities , 2014, Journal of biopharmaceutical statistics.

[18]  Henry F. Inman,et al.  The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities , 1989 .

[19]  Margaret Gamalo-Siebers,et al.  Propensity‐score‐based priors for Bayesian augmented control design , 2018, Pharmaceutical statistics.

[20]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[21]  D. Rubin Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.

[22]  R. Tiwari,et al.  Propensity score matched augmented controls in randomized clinical trials: A case study , 2018, Pharmaceutical statistics.

[23]  D. Rubin,et al.  Estimating and Using Propensity Scores with Partially Missing Data , 2000 .

[24]  P. Austin An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.